LEO LUZNIK to Immunotherapy
This is a "connection" page, showing publications LEO LUZNIK has written about Immunotherapy.
Connection Strength
0.247
-
Finding the best way to train the immune system against lymphoma. Leuk Lymphoma. 2006 Apr; 47(4):577-9.
Score: 0.105
-
Immune dysfunction signatures predict outcomes and define checkpoint blockade-unresponsive microenvironments in acute myeloid leukemia. J Clin Invest. 2022 11 01; 132(21).
Score: 0.083
-
Successful therapy of metastatic cancer using tumor vaccines in mixed allogeneic bone marrow chimeras. Blood. 2003 Feb 15; 101(4):1645-52.
Score: 0.021
-
Signatures of CD8+ T cell dysfunction in AML patients and their reversibility with response to chemotherapy. JCI Insight. 2018 11 02; 3(21).
Score: 0.016
-
Immunomodulatory Drugs: Immune Checkpoint Agents in Acute Leukemia. Curr Drug Targets. 2017; 18(3):315-331.
Score: 0.014
-
Immunologic recovery following autologous stem-cell transplantation with pre- and posttransplantation rituximab for low-grade or mantle cell lymphoma. Ann Oncol. 2010 Jun; 21(6):1203-1210.
Score: 0.008